Objectives: To extend the mutant selection window (MSW) hypothesis to include antibiotics in addition to fluoroquinolones, the pharmacodynamics of daptomycin (DAP) and vancomycin (VAN) and their ability to prevent the selection of resistant Staphylococcus aureus were studied in an in vitro model that simulates antibiotic concentrations below the MIC, between the MIC and the mutant prevention concentration (MPC), and above the MPC. VAN 11 mg/L), were exposed for five consecutive days to once-daily daptomycin (half-life 9 h) and twice-daily vancomycin (half-life 6 h) at the ratio of 24 h area under the concentration-time curve (AUC 24 ) to MIC that varied over a 16-to 30-fold range. The cumulative antimicrobial effect was expressed by its intensity (I E ). Changes in susceptibility and numbers of surviving organisms on agar plates containing 2· and 4· MIC of daptomycin or vancomycin were monitored daily.
Introduction
The hypothesis of the mutant selection window (MSW) , that is the concentration range from the MIC to the mutant prevention concentration (MPC), within which it is proposed that resistant mutants are enriched or selected 1 has passed the test successfully with Staphylococcus aureus [2] [3] [4] [5] [6] and Streptococcus pneumoniae in vitro models. 3, 7 Despite the use of different dynamic models, the most pronounced loss in susceptibility of antibiotic-exposed organisms and the enrichment of resistant mutants were reported over a comparable range of simulated ratios of 24 h area under the concentration-time curve (AUC 24 ) to MIC (from 25 to 100-150 h), when antibiotic concentrations fell into the MSW for most of the dosing interval.
To extend the MSW hypothesis beyond fluoroquinolones, two strains of S. aureus were exposed to daptomycin and vancomycin pharmacokinetics at concentrations below the MICs, between the MICs and MPCs, and above the MPCs in a dynamic model that simulates 5 day treatments with the two antibiotics.
Materials and methods

Antimicrobial agents, bacterial strain and susceptibility testing
Daptomycin and vancomycin were kindly provided by Cubist Pharmaceuticals, Inc. (Lexington, MA, USA) and MP Biomedicals, Inc. (Solon, CA, USA), respectively.
Two clinical isolates of S. aureus, that is S. aureus 866 (methicillin-resistant S. aureus, MRSA) and S. aureus 10 (methicillin-susceptible S. aureus, MSSA) were selected for the study. Susceptibility testing was performed in triplicate by broth microdilution techniques at 24 h post-exposure with the organism grown in Mueller-Hinton broth (MHB) at an inoculum size of 10 6 cfu/mL. Because daptomycin antimicrobial activity is influenced by the presence of Ca 2+ , 8 MHB supplemented with 50 mg of Ca 2+ /L was used for all susceptibility studies. With S. aureus 866 and S. aureus 10, the MICs of daptomycin were estimated at 0.35 and 1.1 mg/L, respectively, and the MICs of vancomycin were 0.7 and 1.3 mg/L, respectively. To reveal possible changes in susceptibility of antibiotic-exposed staphylococci, the MICs were determined prior, during and after a 5 day treatment.
The MPCs were determined as described elsewhere. 1 Briefly, the tested microorganisms were cultured in MHB and incubated for 24 h. Then, the suspension was centrifuged (4000 g for 10 min) and resuspended in MHB to yield a concentration of 10 11 cfu/mL. A series of agar plates containing known antibiotic concentrations was then inoculated with 10 11 cfu of S. aureus. The inoculated plates were incubated for 48 h at 37 C and screened visually for growth. To estimate the MPC, logarithms of bacterial numbers were plotted against antibiotic concentrations (Figure 1 ). MPC was taken as the point where the plot intersected the theoretical limit of detection (log cfu/mL = 1).
The MPCs of daptomycin and vancomycin were estimated at 1.1 and 2.4 mg/L for S. aureus 866, and 5.5 and 11 mg/L for S. aureus 10, respectively.
Simulated pharmacokinetic profiles
Mono-exponential concentration decays of daptomycin (as a single dose) and vancomycin (as two 12 hourly doses) were simulated for five consecutive days with half-lives of 9 and 6 h, respectively, in accordance with values reported in humans. [9] [10] [11] With S. aureus 866 exposed to both antibiotics and with daptomycin-exposed S. aureus 10, the simulated AUC 24 /MIC ratios were 16, 32, 64, 128 and 256 h, and with S. aureus 10 exposed to vancomycin the simulated AUC 24 / MIC ratios were 13, 26, 54, 108, 216 and 432 h. Peak concentrations (C max values) of the antibiotics were equal to the MIC, located between the MIC and the MPC, that is within the MSW, and above the MPC. With S. aureus 866 exposed to both antibiotics and daptomycin-exposed S. aureus 10, the steady-state C max /MIC ratios varied from 1.2 to 20.0 and with S. aureus 10 exposed to vancomycin the ratios varied from 1.5 to 50. Most experiments were performed at least in duplicate.
In vitro dynamic model
A previously described dynamic model was used in this study. 12 Briefly, the model consisted of two connected flasks, one containing fresh MHB supplemented with 50 mg of Ca 2+ /L (daptomycin experiments) and the other with a magnetic stirrer, the central unit, with the same broth containing either a bacterial culture alone 13 or a bacterial culture plus antibiotic (killing/regrowth experiments). Peristaltic pumps circulated fresh nutrient medium to the flasks and from the central 60 mL unit at a flow rate of 4.6 mL/h with daptomycin and 6.9 mL/h with vancomycin. The reliability of antibiotic pharmacokinetic simulations and the high reproducibility of the time-kill curves provided by the model have been reported elsewhere.
12
The system was filled with sterile MHB and placed in an incubator at 37 C. The central unit containing 54 mL of fresh MHB was inoculated with 6 mL of an 18 h culture of S. aureus (10 9 cfu/mL). After a 30 min incubation daptomycin or vancomycin was injected into the central unit.
Quantification of the antimicrobial effect and susceptibility changes
In each experiment, multiple sampling of bacteria-containing medium from the central compartment was performed throughout the observation period. Samples (100 mL) were serially diluted as appropriate, and 100 mL was plated onto Mueller-Hinton agar plates. The duration of the experiments was defined in each case as the time after the last dose until antibiotic-exposed bacteria reached the maximum numbers observed in the absence of antibiotic (10 9 cfu/mL). The lower limit of accurate detection was 2·10 2 cfu/mL. Based on time-kill data, the intensity of the antimicrobial effect (I E ) 13 was determined from time zero to the time at which the number of antibiotic-exposed bacteria reached 10 8 cfu/mL. The computation of I E is depicted graphically in Figure 2 .
To reveal possible changes in susceptibility during treatment, MICs for bacterial cultures sampled from the model were determined daily for 5 days. Moreover, each sample was plated onto agar plates containing 2· and 4· MIC of daptomycin or vancomycin.
Relationships of the antimicrobial effect to AUC 24 /MIC
The I E -log AUC 24 /MIC curve was fitted by the logistic function:
where x is the AUC 24 /MIC ratio, E is I E , E max and E min are the maximal and minimal values of the antimicrobial effect, x 50 is x corresponding to (E min + E max )/2 and s is a parameter reflecting sigmoidicity.
Relationships of the emergence of resistance to AUC 24 /MIC 
where Y is the MIC final /MIC initial ratio or log N max /N initial , Y 0 is the minimal value of Y, x is the log AUC 24 /MIC, x c is the log AUC 24 / MIC that corresponds to the maximal value of log N max /N initial or MIC final /MIC initial , and a and b are parameters. Equation 2 was also used to fit N max /N initial or MIC final /MIC initial versus AUC/MPC data.
To relate the emergence of resistance with the time during which antibiotic concentrations are within the MSW (T MSW 6 ), the log N max / N initial or MIC final /MIC initial ratio was fitted to the T MSW s using Equation 1 , where E is either log N max /N initial or the MIC final /MIC initial , x is T MSW and x 50 is the T MSW that corresponds to (E min + E max )/2.
Results
Pharmacodynamics
The time courses of killing and regrowth of S. aureus 866 exposed to daptomycin and vancomycin are shown in Figure 3 . The lowest simulated AUC 24 /MIC ratio (16 h) with C max /MICs close to the MICs did not reduce the starting inoculum. The higher AUC 24 /MICs, with daptomycin and vancomycin C max /MICs exceeding the MICs over a considerable part of the dosing interval (AUC 24 /MIC 32 h) or the entire dosing interval (AUC 24 /MIC 64-256 h), resulted in pronounced reductions in bacterial counts, although regrowth occurred by the end of each treatment. In general, an increase in the simulated AUC 24 /MIC ratio led to the lower minimal numbers of surviving organisms and to later regrowth. Similar AUC 24 /MIC-dependent killing was observed with daptomycin-and vancomycin-exposed S. aureus 10 (data not shown).
Plotting I E versus log AUC 24 /MIC (Figure 4) gives a sigmoid curve that is not specific for antibiotic or for bacterial strain: Equation 1 fits combined data obtained with each antibioticpathogen pair. Given the strain-independent pattern of the I E -log AUC 24 /MIC relationship, it can predict daptomycin and vancomycin effects on a hypothetical strain of S. aureus, for example, a strain with MICs equal to the MIC 90 s (1 and 2 mg/L, respectively).
14 As seen in the figure, at the clinically achievable AUC 24 /MIC 90 ratios (380 and 570 h for 4 and 6 mg/kg daptomycin, respectively, and 200 h for 2· 1 g vancomycin), the predicted effects of both antibiotics are quite similar. 
Discussion
The MSW hypothesis was shown to be relevant to the studied lipopeptide and glycopeptide antibiotics: both selection of organisms resistant to 2· and 4· MIC of daptomycin or vancomycin and decreased susceptibility of staphylococci occurred at antibiotic concentrations that fell into the MSWs. Antibiotic-and bacterial strain-independent bell-shaped relationships between MIC final /MIC initial and AUC 24 /MIC were similar to those reported in in vitro studies with fluoroquinolones [5] [6] [7] although AUC 24 /MIC plots of resistance of S. aureus to daptomycin and vancomycin were more scattered. However, maximal enrichment of resistant mutants and significant loss in susceptibility of daptomycin-or vancomycin-exposed S. aureus were observed at AUC 24 /MIC ratios (30-60 h) that are comparable with those reported with the fluoroquinolones and S. aureus: from 25 to 100 h 6 and from 30 to 150 h 3 for ciprofloxacin, from 25 to 100 h for gatifloxacin, 4,6 levofloxacin 5, 6 and moxifloxacin 6 and from 60 to 120 h for ABT-492, 5 but not with findings reported in a recent study with levofloxacin-exposed staphylococci, 15 where the enrichment of resistant mutants was observed only at an AUC 24 /MIC of 30 h but not at 60 h.
Recently, the ratio of AUC to MPC of ciprofloxacin was suggested to be a better predictor of the enrichment of resistant Escherichia coli than AUC/MIC, 16 although this statement was not entirely supported by the presented data. In the present study, neither MIC final /MIC initial ( Figure 9 ) nor N max /N initial (data not shown) correlated with the AUC 24 /MPC ratio. Further studies examining AUC 24 /MPC relationships of resistance with additional antibiotics are needed to compare different predictors of resistant mutant enrichment.
Unlike our earlier findings with fluoroquinolones, 6 less accurate relationships were established in this study when log N max /N initial or MIC final /MIC initial were plotted against the T MSW . At first glance, this is consistent with the unsuccessful attempts to relate resistance of ciprofloxacin-exposed S. aureus to T MSW as reported by Campion et al. 3 However, this similarity is more apparent than real. Looking closely at the MIC final /MIC initial versus T MSW data reported in the ciprofloxacin study, a reasonable T MSW relationship of resistance could be seen in simulations of conventional dosing regimens but not continuous infusions (C maxto-trough ratios of 6.6 and unity, respectively). It is possible that these data cannot be combined because the enrichment of the resistant mutants might depend on the shape of the simulated pharmacokinetic profile. In our study that simulated normal and impaired gatifloxacin elimination, 4 more pronounced loss in susceptibility of S. aureus was observed when concentrations oscillated significantly (C max /trough ratio of 10.8) compared with less oscillating concentrations (C max /trough ratio of 1.7). On the other hand, the simulated constant ciprofloxacin concentrations were so close to the MIC (antibiotic concentrations exceeded the MICs by a factor of 1.2) that the actual T MSW might better be described equal to zero rather than 100%. Another study that also declared the inability of T MSW to predict the selection of resistant staphylococci based their conclusions on single bolus dose or infusion of ciprofloxacin. 16 In this design the true T MSW relationships with resistance may not be demonstrated. Further studies that simulate multiple-dose pharmacokinetics are needed to better examine T MSW and other potential in vitro predictors of resistant mutant selection.
AUC 24 /MIC relationships of the I E and N max /N initial or MIC final /MIC initial ratios established in this study predict similar effects of clinical doses of both antibiotics and a greater ability of daptomycin to prevent the selection of resistant staphylococci relative to vancomycin. However, these predictions ignore the different protein binding of daptomycin (92%) 9 and vancomycin (from 8% to 70%, average 42% 17 and from 20% to 80%, average 55% 18 ). It would seem that this factor could be easily accounted for if clinically achievable AUC 24 /MIC 90 ratios that correspond to total concentrations (380 h for 4 mg/kg daptomycin, 570 h for 6 mg/kg daptomycin and 200 h for 2· 1 g vancomycin) were simply replaced by the respective ratios calculated by multiplying AUC 24 /MIC 90 s by the free fractions determined in equilibrium dialysis or ultrafiltration studies. Assuming daptomycin binding of 92% 9 and vancomycin binding of 42%, 17 the respective AUC 24,free /MIC 90 s in this scenario would be as low as 30-45 h and 116 h. As a result, the predicted effects of daptomycin on susceptible and resistant sub-populations would be much less than those based on total concentrations.
However, recent studies that simulate antibiotic concentrations with and without albumin or blood serum [19] [20] [21] [22] [23] raise questions of whether the described method to consider protein-binding effects is correct. For example, in an in vitro study with seven differentially bound antibiotics (from 2% to 94%), simulated 'free' concentrations, that is those derived from reported percentage of protein binding, exhibited much less killing of S. aureus than their total concentrations in the presence of albumin. 23 In a previous study, no protein-binding effects on the killing of S. aureus, S. pneumoniae and E. coli were found with three differentially bound quinolones in a static in vitro study. 22 In another static study that exposed the same bacterial species plus Klebsiella pneumoniae to 95% bound ertapenem and faropenem, 21 their antibacterial activity was dramatically decreased in the presence of 50% human serum. These effects were observed at low but not at higher antibiotic concentrations, which, at least with S. aureus, were still much lower than clinically achievable values making the clinical relevance of these reported effects unclear. In addition, another study reported only minor effects of bovine albumin on the killing of S. pneumoniae and E. coli exposed to constant concentrations of 95-98% bound ceftriaxone. 20 Recently, only minimal, if any, differences in the antistaphylococcal effects of 94%-bound telavancin were found in the presence or absence of albumin. 19 Unfortunately, several reported in vitro studies with highly bound daptomycin [24] [25] [26] [27] [28] [29] [30] have not resulted in a better understanding of protein-binding effects on bacterial killing and susceptibility. For example, killing of daptomycin-exposed S. aureus at simulated total concentrations plus albumin was less than without albumin but greater than that with simulated 'free' concentrations. 28 In another study with the same bacterial strain, simulated 'free' concentrations were more efficient than simulated total concentrations in the presence of albumin. 24 Therefore, insistence on simulations of 'free' daptomycin concentrations is not wellfounded. Moreover, a 4-to 5-fold increase in daptomycin MICs determined in albumin-supplemented broth or human serum 31 suggests that daptomycin is more active than might be predicted from reported free fractions. On the other hand, the difference between daptomycin MICs determined with and without albumin should not be the basis for estimating the 'effective value' of protein binding and the respective correction of the total concentration-based AUC 24 /MIC relationships of bacterial killing and resistance. For example, albumin-induced increases in daptomycin MICs reported with various strains of S. aureus varied from 2-to 16-fold 28 and from 4-to 32-fold. 27 Taken together these findings suggest that attempts to interpret the pharmacodynamics of antibiotics using reported percentages of protein binding are inappropriate and fraught with serious underestimation of the true antimicrobial activity, both in vitro and in vivo. For example, an attempt in infected neutropenic mice to relate the antistaphylococcal effects of free concentrations of telavancin calculated from reported percentages of protein binding was disappointing: pronounced reductions in bacterial titres were observed at 'free' concentrations below the MIC throughout the entire dosing interval (time above MIC of zero). 32 As for in vitro studies that examine bacterial killing kinetics in the presence of serum, albumin and/or other macromolecules, the definitive methodology is still to be established. Until then, incorrect considerations of protein-binding effects might be even more dangerous than ignoring this factor.
Turning back to the primary goal of this study, we can conclude that data obtained with daptomycin-and vancomycinexposed S. aureus are in support of the MSW hypothesis. Also, this study suggests that an antibiotic-and bacterial strainindependent relationship exists between an integral index of the entire antimicrobial effect, I E and the AUC 24 /MIC ratio as simulated in vitro.
